How does Becaplermin Gel actually make a diabetic foot ulcer heal faster?
Becaplermin Gel contains a human growth factor (rhPDGF-BB) that signals your body's cells to multiply and rebuild skin tissue. Clinical trials show it closes diabetic foot ulcers 30% faster than standard wound care alone, with complete healing in 20 weeks instead of 25 [1].
The federal trial data is rock-solid. A phase III randomized controlled trial of 922 diabetic patients found that 48% of ulcers treated with Becaplermin Gel closed completely within 12 weeks, compared to just 25% in the placebo group [1]. That's a 23-percentage-point advantage—the kind of number that earned FDA approval in 1997 and has kept the drug on the market for 25+ years [9].
Here's what happens inside your wound. Becaplermin Gel mimics a natural growth signal called platelet-derived growth factor (PDGF), which tells fibroblast cells (the builders of skin) to wake up and multiply. In a diabetic foot ulcer, blood sugar damage has silenced these cells. The gel reactivates them, triggering collagen deposition and new blood vessel formation—essentially teaching your body to rebuild what diabetes broke [5].
The real-world trade-off is timing and cost. You apply the gel once daily for 8 to 24 weeks, which means discipline and dressing changes every single day. Insurance typically covers $50–$150 per tube (you need 4 tubes per month), but uninsured patients pay $328 per tube. If your ulcer doesn't show 20% improvement after 4 weeks, stop the gel—it won't help, and you'll waste money [7].
Before starting Becaplermin Gel, ask your wound-care doctor: 'Is my ulcer clean and free of dead tissue, and does my foot have good blood flow?' If the answer is no to either, the gel won't work. Get those issues fixed first, then start the gel [1].